SKIN - Beauty Health Stock Plunges After Q3 Print: Analysts Take A Deep Dive Challenges 'More Than Skin Deep' | Benzinga
Beauty Health Co (NASDAQ: SKIN) shares tanked in early trading on Tuesday, after reporting downbeat quarterly results.
The results came amid an exciting earnings season.
Here are some key analyst takeaways from the earnings release.
Benchmark On Beauty Health
Analyst Bruce Jackson downgraded the rating from Buy to Hold.
Beauty Health reported disappointing third-quarter results, lowered its full-year guidance, suspended the targets for 2025 and indicated that "addressing the product issues experienced after last year’s U.S. Syndeo launch would take additional time to address,” Jackson said in his downgrade note.
"The delivery system meant to fix the performance issues with the first-generation product itself was found to have flow issues after 4-6 months in the field,” the analyst stated.
He added that U.S. Syndeo customers ...